These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 161523)

  • 1. Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: final results.
    Grossman RA; Asawasena W; Chalpati S; Taewtong D; Tovanabutra S
    Bull World Health Organ; 1979; 57(5):829-37. PubMed ID: 161523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: results after six months.
    Grossman RA; Assawasena V; Chalpati S; Taewtong D
    Bull World Health Organ; 1977; 55(1):67-78. PubMed ID: 302157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuation of injectable contraceptives in Thailand.
    Narkavonnakit T; Bennett T; Balakrishnan TR
    Stud Fam Plann; 1982 Apr; 13(4):99-105. PubMed ID: 6216633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M; Guarnaccia M; Alon J; Wiley J
    Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
    Westhoff C
    J Reprod Med; 1996 May; 41(5 Suppl):401-6. PubMed ID: 8725702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactorrhea in DMPA users: incidence and clinical significance.
    Gongsakdi D; Rojanasakul A
    J Med Assoc Thai; 1986 Jan; 69(1):28-32. PubMed ID: 2937870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
    Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC
    Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
    Pongsatha S; Ekmahachai M; Chaovisitsaree S; Suntornlimsiri N; Morakote N
    J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of medroxyprogesterone acetate contraception on human serum enzymes.
    Mukherjea M; Mukherjee P; Biswas R; Chakraborty AS; Kushari J
    Int J Fertil; 1981; 26(1):35-9. PubMed ID: 6113206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
    Kaunitz AM
    J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
    Nelson AL
    J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Injectable contraceptive, DMPA, serum HDL cholesterol and heart infarct].
    Kremer J; de Bruijn HW; Hindriks FR
    Ned Tijdschr Geneeskd; 1981 Aug; 125(35):1418-21. PubMed ID: 6456421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM
    Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of injectable contraceptive users in a low-income population in Texas.
    Sangi-Haghpeykar H; Poindexter AN; Moseley DC; Bateman L; Reid ED
    Fam Plann Perspect; 1995; 27(5):208-11, 225. PubMed ID: 9104608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study of breast cancer and hormonal contraception in Costa Rica.
    Lee NC; Rosero-Bixby L; Oberle MW; Grimaldo C; Whatley AS; Rovira EZ
    J Natl Cancer Inst; 1987 Dec; 79(6):1247-54. PubMed ID: 2961909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of medroxyprogesterone acetate on serum lipids, protein, glucose tolerance and liver function in Thai women.
    Amatayakul K; Sivassomboon B; Singkamani R
    Contraception; 1980 Mar; 21(3):283-97. PubMed ID: 6446443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study.
    Brito MB; Ferriani RA; Quintana SM; Yazlle ME; Silva de Sá MF; Vieira CS
    Contraception; 2009 Dec; 80(6):519-26. PubMed ID: 19913145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.